GoldNApel FB Update!! GoldNApel 10/10/2013. Hi

New Post Public Reply Private Reply Replies (6) Message Board
on41greyst
GoldNApel FB Update!!

GoldNApel 10/10/2013.

Hi Everybody,

I have been carrying on a conversation with Chris on the facebook message feature. He recently inquired if we were still active because he hadn't heard from me for a few days, as we were quite busy. I wrote him a long reply and realized that it might be good to share it with everyone. Here it is:

Hi Chris,

Yes we are active and we have been working very hard. Sorry I was slow in replying. That time of the year! Harvest time for a strain of Cannatonic that yielded over 17% CBD several years back. Waiting for tests on this year's efforts. Hopefully we have the THC down to near nothing, but actually, it doesn't matter all that much anymore. We can now preserve all of the cannabinoids in their non-psychoactive form with the new technology that Dr. Apel has developed over the last year or so, and that we announced today.

The "game-changer" we talked about a while back is here. I really believe that our new Dharmanol preparation will enable a cancer patient to take 10 or more times the cannabinoids that are recommended in Simpson therapy, and there may well be no cancer that can stand up to this kind of treatment in an otherwise-healthy individual. Everything we have seen in this field of research indicates that this may well be true.

I will never claim a "cure" until we have some double-blind placebo-controlled tests of the type Dr. Abrams wants to do, if the government would ever give him some "official" cannabis oil to experiment with, but even a person with no formal education in science can go online, google keywords like "cannabis cancer" and do many hours of informative reading from reputable scientific sources.

I would think that anyone with an interest in what SK3 and BBio are doing would perform this simple task and see what the current research is saying. Even the staunchest skeptic, with a bit of reading and study, would likely agree that cannabinoid therapy is indeed a treatment for cancer that holds a great deal of promise for mankind. That is why I find it so hard to believe that there are those who try so hard to question everything that we are doing, and present all of our activities in the worst possible light on the message boards.

(By the way, I will scan the boards on a day such as today, but all of us are far too busy building our respective parts of this company to put much time and effort into the boards).

Several months ago I said that I would answer any questions here that I could from those who speculate on the message boards, and I appreciate your starting a conversation with me, but I have received very few questions.

The announcement today was just a part of where we see this going. We now have the capacity to remove the psychoactivity from the kind herb, and make it truly a kind medicine, for all of those in need of healing. There are several different delivery systems we are working on, as well as combinations with other healing herbs and supplements, providing Dharmanol-based medicines tailored specifically for a variety of the ailments that cannabinoid therapy has shown to be effective in treating.

Thanks again for the conversation. I will always do my best to keep a good dialogue going.

Dave

While I'm at it, let me clarify low-dose and high-dose Dharmanol. The low-dose tablets are designed for daily health maintenance with a total of 10 mg. of cannabinoids, consisting of 5 mg. CBD and 5 mg. mixed cannabinoid carboxylates (which have been stabilized in their non-psychoactive form), and an additional 5 mg of steam-extracted terpenes and terpenoids from a variety of strains of cannabis. (The terpenes help the cannabinoids bind to the receptors, enhancing the efficacy of the treatment). Also, the steam-extract allows the extraction and inclusion of many different elements of the kind herb which have demonstrated that so-called whole plant medicinals are much better than just the isolated elements, in many cases, and utilizing an extract from the widest variety of strains possible insures that we get some of the entire spectrum of whole-plant goodness.

The purpose of high-dose Dharmanol is to provide the body of a cancer patient with the equivalent of a Simpson dose, but without the psychoactivity or "high". A different delivery system is being prepared for utilizing Dharmanol in high doses for the treatment of serious illnesses, but it is not inconceivable for a person treating cancer to chew 8 low-dose Dharmanol tablets six times a day, which would give a Simpson-sized dose with no side effects, and, in strictly my own opinion, the safest and most promising experimental cancer treatment that is currently being studied in the world of cannabis science.

The ultimate hope for Dharmanol will come in mega-doses that exceed the Simpson norm many times. Simpson's recommended dose is about one ten-thousandth of the LD-50 for marijuana. (LD-50 is the amount of a drug that will kill half of the lab animals to which it is administered). Most cancer drugs are so harmful to the body that the effective dose is a large percentage of the size dose that will cause death.

With the huge ratio between the Simpson dose and the LD-50 for cannabis, there is opportunity to step up the dosage levels many times. The only reason this isn't done is because handling a full gram of strong cannabis oil daily is very difficult for many people, especially by those who have never experienced cannabis. Now that we have removed the psychoactivity and medicinalized the plant, we will soon see the results of people treating serious illnesses with many times the doses possible today.

Cannabis medicine works on both ends of the spectrum. Small daily doses will tune up the body's own endo-cannabinoid system, keeping one healthy. Large doses are doseage-dependent, meaning the more the better. University lab tests have shown that concentrated cannabis medicine, when applied to cancerous tissue, adjacent to healthy tissue, will directly kill the malignant cells, while simultaneously strengthening the healthy ones. Even though there are many other mechanisms that cannabis uses to fight disease, I find this one amazing, and indicative of the special energy that this wonderful plant holds.

Thanks!

Dave

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 2

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

Updated Category News Views 0

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Continue Reading
RealityMine Appoints CPO Amidst Strong Growth Momentum

Updated Category News Views 0

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Continue Reading
Moab Launches Free Shuttle to Enhance Park Access

Updated Category News Views 3

Moab's Shuttle: A New Era for Park Access A breeze of change is sweeping through the dusty trails of Moab, Utah, and this isn't just any switch—it's about making the always-packed Arches National Park a bit less of a traffic nightmare. Imagine this: strolling up to a shuttle, no tickets, no cash needed, and you're off to see epic scenery like The Windows and Delicate...

Continue Reading
Associated Banc-Corp Preps for Barclays Financial Conference

Updated Category News Views 1

Associated Banc-Corp Heads to New York for Key Financial Services Conference Wake up and smell the coffee, folks—Associated Banc-Corp (NYSE: ASB) is set to make waves at the 24th Annual Barclays Global Financial Services Conference in New York. From September 14th to 16th, seasoned execs from ASB plan to rub elbows with the industry's heavy hitters, presenting their...

Continue Reading
Axjo Group Expands in France with Eco-Tourets Buy

Updated Category News Views 6

Seizing the French Market: Axjo's Strategic Play Every now and then, you come across a company that's not just talking the talk but walking the green walk. Axjo Group's latest move—scooping up France's Eco-Tourets—puts them squarely in that league. It ain't just about expanding the footprint; it's about owning a piece of the future where sustainability isn't a...

Continue Reading
Flotek Faces Lawsuit: Investors Urged to Act Fast

Updated Category News Views 2

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 4

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 2

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Gargle Bolsters SEO for AI-Driven Dental Searches

Updated Category News Views 1

SEO Revolution: Dental Practices and AI Folks, here's the scoop: Gargle, Inc., a dental marketing powerhouse from Lehi, Utah, is shaking up the SEO game for dental practices. We're talking about building muscle in the world of AI-driven and voice searches. You know, the kind where you ask your assistant about dental pain at 2 AM and expect a trusted response. Forget the...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla's Stock : Why Analysts Are Betting Big on Its Future

Updated Category News Views 22

Tesla’s Stock Gains Traction as Analysts Boost Valuations Tesla, a leader in electric vehicles, continues to capture investor attention as analysts from Canaccord Genuity weigh in with a positive outlook. Recently, the firm maintained a Buy rating on Tesla (NASDAQ: TSLA) and increased its price target to $298.00, up from the previous $278.00. This upward adjustment...

Continue Reading
Verkkokauppa.com Oyj Announces Upcoming Share Buyback Initiative

Updated Category News Views 157

Introduction to Verkkokauppa.com Oyj's Share Buyback Program Verkkokauppa.com Oyj is set to launch a share buyback program that aims to enhance shareholder returns while also reinforcing its commitment to shareholder value. This exciting development follows the authorization granted by the company’s Annual General Meeting earlier this year. Details of the Buyback...

Continue Reading
Derek Rogers Takes Helm at KXII and FXII as General Manager

Updated Category News Views 559

Derek Rogers Takes Charge as the New General Manager ATLANTA, Dec. 05, 2024 -- Gray Television, Inc. (“Gray” or “Gray Media”) (NYSE: GTN) proudly announces the appointment of Derek Rogers as the new General Manager and Director of Sales for KXII (CBS) and FXII (FOX). His official start date will be January 6, 2025, taking over the role from Rick Dean, who is...

Continue Reading
Revolutionizing Air Travel Communication with AI Integration

Updated Category News Views 178

Transforming Air Travel Communication with AI Technology The acquisition of Airport AI by 15below marks a significant advancement in the airline industry, strengthening its AI capabilities and expanding its influence in the airport market. This strategic move aims to create a comprehensive channel for passenger communication, ensuring a seamless journey from check-in to...

Continue Reading
Johnson Pope Welcomes New Attorneys for Enhanced Services

Updated Category News Views 252

Johnson Pope Welcomes New Attorneys for Enhanced Services Johnson, Pope, Bokor, Ruppel & Burns, LLP is excited to share the positive news of welcoming two talented associate attorneys, Jessica Warwick and Samuel C. Craig, to its growing team. This move marks a significant milestone for the firm in their mission to provide unparalleled legal services to clients. Strategic...

Continue Reading